In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
D000667:Ampicillin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002861:Chromobacterium / Q000187:drug effects; D003091:Colistin / Q000494:pharmacology; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000187:drug effects; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D005601:Framycetin / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D011113:Polymyxins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000382:microbiology
D005493:Folic Acid Antagonists; D005839:Gentamicins; D011113:Polymyxins; D011743:Pyrimidines; D009268:Nalidixic Acid; D005601:Framycetin; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D013420:Sulfamethoxazole; D002509:Cephaloridine; D013307:Streptomycin; D003091:Colistin